4656983 samples
Export
<<< of 232850>>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterSRA
GSM8098257
pos_ctl+pid 1-X per treatment/timepoint group rep 4
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098258
pos_ctl+pid 1-X per treatment/timepoint group rep 5
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098259
pos_ctl+pid 1-X per treatment/timepoint group rep 6
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098260
pos_ctl+pid 1-X per treatment/timepoint group rep 7
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098261
pos_ctl+pid 1-X per treatment/timepoint group rep 8
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098262
pos_ctl+pid 1-X per treatment/timepoint group rep 9
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098263
dmso+nec 1-X per treatment/timepoint group rep 1
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098264
dmso+nec 1-X per treatment/timepoint group rep 2
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098265
dmso+nec 1-X per treatment/timepoint group rep 3
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098266
dmso+nec 1-X per treatment/timepoint group rep 4
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098267
dmso+nec 1-X per treatment/timepoint group rep 5
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098268
dmso+nec 1-X per treatment/timepoint group rep 6
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098269
dmso+nec 1-X per treatment/timepoint group rep 7
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098270
dmso+nec 1-X per treatment/timepoint group rep 8
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098271
dmso+nec 1-X per treatment/timepoint group rep 9
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098272
aav+nec 1-X per treatment/timepoint group rep 1
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098273
aav+nec 1-X per treatment/timepoint group rep 2
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098274
aav+nec 1-X per treatment/timepoint group rep 3
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098275
aav+nec 1-X per treatment/timepoint group rep 4
SRA 1 Richard Virgen-Slane Feb 26, 2024
GSM8098276
aav+nec 1-X per treatment/timepoint group rep 5
SRA 1 Richard Virgen-Slane Feb 26, 2024